News & Awards

Press Releases

Latest News

November 14, 2022 

Nitrase Therapeutics Presented Data on the Importance of Synuclein Nitrase on the Synaptic Activity of Differentiated Dopaminergic Neurons at the Society for Neuroscience (SFN) Conference

Read more

October 31, 2022 

Nitrase Therapeutics Presented Data on Role of Novel Nitrases in Regulating Known and Important Cancer Targets at EORTC-NCI-AACR Symposium

Read more

September 7, 2022 

Nitrase Therapeutics Appoints Arun Kashyap, Ph.D., to Lead its Recently Launched Oncology Programs as Senior Vice President of Oncology

Read more

July 6, 2022 

Nitrase Therapeutics Expands Leadership Team with Accomplished Drug Discovery and Development Executives

Read more

June 2, 2022 

Nitrase Therapeutics Expands Pipeline to Include Oncology Programs and Adds Seasoned Cancer Experts to Scientific Advisory Board

Read more

April 5, 2022 

Nitrase Therapeutics Receives New Grant from The Michael J. Fox Foundation for Parkinson’s Research

Read more

March 18, 2022 

Nitrase Therapeutics Announces Major Discovery In Parkinson’s Disease Presented At The AD/PD International Conference

Read more

November 2, 2021

Nitrome Biosciences Appoints Pierre Beaurang, Ph.D., as Chief Executive Officer, Expands Series A to $45M, and Changes Company Name to Nitrase Therapeutics

Read more

November 12, 2020

Nitrome Biosciences Announces Formation of Scientific Advisory Board and Appointment of Former AbbVie Executive James Summers, Ph.D. to SAB Chairperson

Read more

October 13, 2020

Nitrome Biosciences Appoints Industry Veteran Perry Karsen as Executive Chairman of the Board of Directors

Read more

April 21, 2020

Nitrome Biosciences Raises $38M Series A Financing to Advance Therapeutics Targeting a Novel Group of Enzymes involved in Age-related Diseases

Read more